BlackRock Institutional Trust’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$23.3M Sell
221,071
-458
-0.2% -$48K ﹤0.01% 1859
2016
Q3
$24.5M Buy
221,529
+9,012
+4% +$1.19M ﹤0.01% 1745
2016
Q2
$30.9M Buy
212,517
+106,856
+101% +$15.2M 0.01% 1552
2016
Q1
$15.1M Buy
105,661
+7,070
+7% +$1M ﹤0.01% 1998
2015
Q4
$15.2M Buy
98,591
+95,116
+2,737% +$13.9M ﹤0.01% 2044
2015
Q3
$497K Sell
3,475
-10,228
-75% -$1.43M ﹤0.01% 3498
2015
Q2
$1.97M Sell
13,703
-2,162
-14% -$308K ﹤0.01% 3126
2015
Q1
$2.24M Buy
15,865
+3,649
+30% +$562K ﹤0.01% 3072
2014
Q4
$1.81M Buy
12,216
+10,148
+491% +$1.49M ﹤0.01% 3145
2014
Q3
$318K Sell
2,068
-10,186
-83% -$1.53M ﹤0.01% 3558
2014
Q2
$1.72M Buy
12,254
+1,190
+11% +$132K ﹤0.01% 3257
2014
Q1
$1.23M Sell
11,064
-1,295
-10% -$141K ﹤0.01% 3348
2013
Q4
$1.22M Sell
12,359
-2,883
-19% -$250K ﹤0.01% 3340
2013
Q3
$1.16M Sell
15,242
-2,686
-15% -$174K ﹤0.01% 3318
2013
Q2
$1M Buy
+17,928
New +$1.06M ﹤0.01% 3334

Other funds holding TARO

BlackRock Institutional Trust's TARO Position: Q4 2016 in Review

BlackRock Institutional Trust reduced its Taro Pharmaceutical Industries Ltd. (TARO) stake by 0.21% in Q4 2016, selling an estimated $48K and leaving 221,071 shares worth $23.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1859.

BlackRock Institutional Trust first reported a position in TARO in Q2 2013 and has held it in 15 quarters since. The position peaked at $30.9M in Q2 2016. 151 funds tracked by Wall St. Rank hold TARO as of Q4 2016.

  • BlackRock Institutional Trust held 221,071 shares of Taro Pharmaceutical Industries Ltd. worth $23.3M as of Q4 2016.
  • BlackRock Institutional Trust sold 458 Taro Pharmaceutical Industries Ltd. shares in Q4 2016, an estimated $48K.
  • Taro Pharmaceutical Industries Ltd. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #1859 holding.
  • BlackRock Institutional Trust first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Taro Pharmaceutical Industries Ltd. position peaked at $30.9M in Q2 2016.
  • 151 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.